临床外科杂志 ›› 2024, Vol. 32 ›› Issue (8): 814-817.doi: 10.3969/j.issn.1005-6483.2024.08.009

• 论著 • 上一篇    下一篇

微孔穿刺引流联合尿激酶治疗对脑出血后脑水肿程度及血清丙二醛、基质金属蛋白酶-9和细胞黏附分子-1水平的影响

  

  1. 252600   山东省聊城市第二人民医院重症医学科(王文涛、 王力明),护理部(闫春林),神经外科(王传刚) 
  • 收稿日期:2024-01-26 修回日期:2024-01-26 接受日期:2024-01-26 出版日期:2024-08-20 发布日期:2024-08-20
  • 通讯作者: 王传刚,Email:453291646@qq.com

Effects of minimally invasive puncture and drainage combined with urokinase on the severity of cerebral edema,serum malondialdehyde,matrix metalloproteinase9 and intercellular adhesion molecule1 after cerebral hemorrhage

  1. Department of Intensive Care Unit,The Second People’s Hospital of Liaocheng,Liaocheng 252600,China
  • Received:2024-01-26 Revised:2024-01-26 Accepted:2024-01-26 Online:2024-08-20 Published:2024-08-20

摘要: 目的  观察微孔穿刺引流术(对照组)联合尿激酶(UK)治疗对脑出血后脑水肿程度及血清丙二醛(MDA)、基质金属蛋白酶-9(MMP-9)和细胞黏附分子-1(ICAM-1)水平的影响。方法  2020年1月~2022年9月在我院收治的高血压性脑出血(HICH)病人82例,根据不同治疗方案分为两组,观察组44例,采用对照组联合UK治疗,对照组38例,采用对照组治疗。观察两组病人脑水肿体积、神经功能[美国国立卫生研究院卒中量表(NIHSS)]、血清学指标MDA、MMP-9和ICAM-1。记录术后并发症发生情况,对比两组术后3个月的预后情况[格拉斯哥结局量表评分(GOS)、日常生活能力(ADL)评分和死亡情况]。结果  术后14天,观察组的周围脑水肿体积为(14.76±2.39)ml,低于对照组的(16.87±2.24)ml,差异有统计学意义(P<0.05);观察组NIHSS评分为(11.12±1.96)分,低于对照组的(11.96±1.65)分。两组比较,差异有统计学意义(P<0.05);观察组的血清MDA、MMP-9、ICAM-1水平分别为(8.65±1.16)nmol/ml、(96.17±19.34)ng/ml和(624.31±32.76)μg/ml,均低于对照组的(16.14±2.16)nmol/ml、(120.47±21.32)ng/ml和(661.24±35.21)μg/ml。两组比较差异有统计学意义(P<0.05)。观察组术后并发症发生率为9.09%,与对照组的18.42%比较,差异无统计学意义(P>0.05)。两组术后3个月内均无死亡病例。观察组术后3个月的GOS评分和ADL评分分别为(4.03±0.92)分、(71.21±12.65)分,均高于对照组的(3.52±1.12)分、(62.98±15.58)分,两组比较差异有统计学意义(P<0.05)。结论  HICH病人应用对照组联合UK治疗可有效控制脑水肿,下调MDA、MMP-9、ICAM-1水平,保护神经功能,改善预后。

关键词: 微孔穿刺引流术, 尿激酶, 脑出血, 脑水肿

Abstract: Objective  To observe the effects of minimally invasive puncture and drainage combined with urokinase on the severity of cerebral edema,serum malondialdehyde(MDA),matrix metalloproteinase-9(MMP-9) and intercellular adhesion molecule-1(ICAM-1) after cerebral hemorrhage.Methods A total of 82 patients with hypertensive intracerebral hemorrhage(HICH) admitted to our hospital were retrospectively enrolled between January 2020 and September 2022.According to different treatment methods,they were divided into two groups: observation group (44 cases, control group combined with UK) and control group (38 cases,control treatment).The cerebral edema volume,nerve function [National Institutes of Health Stroke Scale(NIHSS)] and serological indexes(MDA,MMP-9,ICAM-1) in both groups were observed.The occurrence of postoperative complications was recorded.The prognosis [scores of Glasgow Outcome Scale(GOS) and activity of daily living scale(ADL),death] in the two groups was compared at 3 months after surgery.Results  At 14d after surgery,peripheral cerebral edema volume in the observation group was smaller than that in the control group[(14.76±2.39) ml vs(16.87±2.24) ml,P<0.05],NIHSS score was lower than that in the control group[(11.12±1.96) points vs(11.96±1.65) points,P<0.05].The levels of serum MDA,MMP-9 and ICAM-1  in the observation group were (8.65±1.16)nmol/ml,(96.17±19.34)ng/ml and (624.31±32.76)μg/ml,respectively,which were lower than those in the control group[(16.14±2.16) nmol/ml,(120.47±21.32) ng/ml,(661.24±35.21)μg/ml,P<0.05].There was no significant difference in incidence of postoperative complications between the observation group and the control group(9.09% vs 18.42%,P>0.05).There was no death in either group within 3 months after surgery.At 3 months after surgery,GOS and ADL scores in the observation group were (4.03±0.92) points and (71.21±12.65) points,which were higher than those in the control  group[(3.52±1.12) points,(62.98±15.58) points,P<0.05].Conclusion  The control combined with UK can effectively control cerebral edema,down-regulate MDA,MMP-9 and ICAM-1 levels,protect nerve function and improve prognosis in HICH patients.

Key words: minimally invasive puncture and drainage, urokinase, cerebral hemorrhage, cerebral edema

[1] 王娜 孙伟伟 邢国靖 赵金雷 孙群. 血清基质金属蛋白酶-9、热休克蛋白47水平与急性脑出血术后预后的关系[J]. 临床外科杂志, 2024, 32(8): 818-821.
[2] 张建平 吴日乐 包金岗. 神经内镜下经额锁孔入路治疗中等量基底节区高血压性脑出血的临床效果观察[J]. 临床外科杂志, 2024, 32(4): 377-380.
[3] 柳爱军 王玉华 宋金东 苏海涛 韩宁 王坤. 脑出血病人血清P2X7R水平与脑水肿程度及认知功能相关性研究[J]. 临床外科杂志, 2023, 31(9): 830-833.
[4] 魏航宇 蔡强 李知阳 宋平 周龙 雷盼 高论 程利 华秋伟. 改良微创手术入路与钻孔引流手术治疗自发性幕上脑出血的疗效比较[J]. 临床外科杂志, 2023, 31(3): 228-232.
[5] 李晓玉 汤海琴 徐小琴 江庆. 经锁孔入路手术对颅脑外伤伴脑出血病人恢复情况及D-二聚体、同型半胱氨酸水平表达的影响[J]. 临床外科杂志, 2023, 31(2): 156-158.
[6] 张振华 于宁 郭校 朱明欣. 基质衍生因子-1 联合趋化因子受体4预测高血压脑出血早期血肿扩大应用与价值[J]. 临床外科杂志, 2023, 31(11): 1031-1034.
[7] 李锋 邸方. 早期肠内营养对高血压脑出血病人术后脑积水的作用分析[J]. 临床外科杂志, 2022, 30(10): 930-933.
[8] 王根, 汤德刚, 王维东. 皮层造瘘及脑沟间入路手术治疗自发性基底节区脑出血的临床价值[J]. 临床外科杂志, 2020, 28(6): 541-544.
[9] 伍博, 周赤忠, 潘德锐. 3Dslicer软件辅助定位老年高血压脑出血微创治疗的临床应用[J]. 临床外科杂志, 2020, 28(6): 537-540.
[10] 隋宇玲. 外侧裂入路手术治疗基底节区高血压脑出血的疗效分析[J]. 临床外科杂志, 2020, 28(2): 137-139.
[11] 王策 蔡廷江 鹿海龙 孙凌梅 彭文娟 张文秀. 三种不同手术方式治疗高血压性脑出血的疗效及术后再出血危险因素探讨[J]. 临床外科杂志, 2020, 28(10): 930-933.
[12] 江荣才. 需强调重型脑外伤病人的年龄和病程分层治疗[J]. 临床外科杂志, 2020, 28(10): 911-913.
[13] 陈迎春, 尧小龙, 别毕洲, 汪志忠, 冯娟娟, 张纯, 李欢欢, 盛柳青, 李俊. 定位导向双靶点双通道锥颅治疗高血压脑出血的疗效分析[J]. 临床外科杂志, 2019, 27(8): 674-676.
[14] 周晓飞, 彭金燕, 刘燕. 微创手术在脑出血治疗中的安全性及对病人血清Cys-C、AQP4的影响[J]. 临床外科杂志, 2019, 27(8): 671-673.
[15] 石海平, 罗可, 黄伟. 神经内镜微创手术治疗高血压脑出血病人的手术效果及对病人神经功能的影响[J]. 临床外科杂志, 2019, 27(12): 1029-1032.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 张忠伟;刘扬;路明. 痔上黏膜环切术治疗直肠前突所致出口梗阻型便秘的疗效观察[J]. 临床外科杂志, 2016, 24(10): 774 .
[2] 万松林;刘韦成;吴云华;等. 胃间质瘤腹腔内破裂出血一例[J]. 临床外科杂志, 2016, 24(10): 807 .
[3] 林伟箭;洪雪辉;许淑镇;等. 吸引器在腹腔镜胃癌根治术中的应用体会[J]. 临床外科杂志, 2016, 24(11): 824 .
[4] 叶向红;彭南海;李维勤. 早期肠内营养联合早期运动促进外科重症患者康复[J]. 临床外科杂志, 2016, 24(12): 960 .
[5] 唐健雄 . 疝和腹壁外科该怎样规范化的持续发展 [J]. 临床外科杂志, 2016, 24(4): 245 .
[6] 闵凯 . 疝修补材料学的新进展与疝外科手术的改进[J]. 临床外科杂志, 2016, 24(4): 257 .
[7] 苏福增 王志 张成等 . 嵌顿性腹股沟疝合并肾病综合征患者的围手术期处理 [J]. 临床外科杂志, 2016, 24(4): 260 .
[8] 冯小仍;陈滨;余斌. 骨盆后环骨折内固定方式的稳定性探究[J]. 临床外科杂志, 2016, 24(5): 332 -0 .
[9] 王光林;冯先才;何前进等 . 内镜切除治疗巨大胃间质瘤的临床效果及安全性分析 [J]. 临床外科杂志, 2016, 24(6): 434 .
[10] 奚新明;万锋 . 枕部经小脑幕入路显微手术治疗松果体区肿瘤65例临床分析 [J]. 临床外科杂志, 2016, 24(6): 472 .